shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Jul 7th - Grief on the frontlines: Fostering healthy grief in ourselves and those who we support [SickKids CCMH Learning Institute]
Jul 7th - Mindfulness techniques to decrease stress and increase resilience: Cultivating attitudes that support wellbeing during COVID-19 [SickKids CCMH Learning Institute]
Jul 8th - Dialectical behaviour therapy (DBT): An introduction to essential components [SickKids CCMH Learning Institute]
Jul 11th - Pathways beyond despair: Re-authoring lives of young people through narrative therapy [SickKids CCMH Learning Institute]
Jul 13th - Narrative Therapy Approaches to Addictions [Narrative Therapy Centre]
schools agencies and other institutional orders (click here)
Now open for browsing 12-6 Mon-Sat and 12-5 Sunday for three people at a time. Pickups still from 9 to 6, Monday to Saturday. Free shipping across Canada for orders over $100. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Progress in Neurotherapeutics and Neuropsychoparmacology
Jeffrey L. Cummings (Edt)
Cambridge University Press / Hardcover / 2006-05-01 / 0521862531
Neuropsychiatry / Psychopharmacology
reg price: $229.95 our price: $ 206.96 (may be subject to change)
184 pages
Not in Stock, usually ships in 7-10 business days

Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.

Jeffrey L. Cummings, MD, is currently Director of both the Deane F. Johnson Center for Neurotherapeutics at UCLA, and the UCLA Alzheimer's Disease Center. He holds the Augustus Rose Professor of Neurology chair, was the Shrinavasan Lecturer in 2004 and the Henderson Lecturer in 2005.

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / Closed Sunday (EST)

search
Click here to read previous issues.
authors
Cummings, Jeffrey L
other lists
Cambridge University Press
Neuropsychiatry
Psychopharmacology
University Presses